503 related articles for article (PubMed ID: 15758646)
21. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
22. [New molecular aspects of cholestatic liver diseases].
Trauner M; Fickert P; Stauber RE
Z Gastroenterol; 1999 Jul; 37(7):639-47. PubMed ID: 10458013
[TBL] [Abstract][Full Text] [Related]
23. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction.
Azer SA; Stacey NH
J Gastroenterol Hepatol; 1996 Apr; 11(4):396-407. PubMed ID: 8713709
[TBL] [Abstract][Full Text] [Related]
24. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
[TBL] [Abstract][Full Text] [Related]
25. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
Molinaro A; Marschall HU
Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular bile salt transport: lessons from cholestasis.
Trauner M; Fickert P; Stauber RE
Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
[TBL] [Abstract][Full Text] [Related]
27. Hepatobiliary transporters and drug-induced cholestasis.
Pauli-Magnus C; Meier PJ
Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
[TBL] [Abstract][Full Text] [Related]
28. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
[TBL] [Abstract][Full Text] [Related]
29. Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.
Trauner M; Fickert P; Zollner G
Semin Gastrointest Dis; 2001 Apr; 12(2):66-88. PubMed ID: 11352122
[TBL] [Abstract][Full Text] [Related]
30. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
[TBL] [Abstract][Full Text] [Related]
31. Disorders of bile formation and biliary transport.
Tomer G; Shneider BL
Gastroenterol Clin North Am; 2003 Sep; 32(3):839-55, vi. PubMed ID: 14562577
[TBL] [Abstract][Full Text] [Related]
32. Cholestasis: the ABCs of cellular mechanisms for impaired bile secretion--transporters and genes.
Shaffer EA
Can J Gastroenterol; 2002 Jun; 16(6):380-9. PubMed ID: 12096302
[TBL] [Abstract][Full Text] [Related]
33. Biliary physiology and disease: reflections of a physician-scientist.
Paumgartner G
Hepatology; 2010 Apr; 51(4):1095-106. PubMed ID: 20373364
[TBL] [Abstract][Full Text] [Related]
34. Cholestasis and cholestatic syndromes.
O'Leary JG; Pratt DS
Curr Opin Gastroenterol; 2007 May; 23(3):232-6. PubMed ID: 17414837
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics of hepatocellular transporters.
Pauli-Magnus C; Meier PJ
Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
[TBL] [Abstract][Full Text] [Related]
36. Fibrates and cholestasis.
Ghonem NS; Assis DN; Boyer JL
Hepatology; 2015 Aug; 62(2):635-43. PubMed ID: 25678132
[TBL] [Abstract][Full Text] [Related]
37. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of cholestatic liver diseases.
Paumgartner G
J Dig Dis; 2010 Jun; 11(3):119-25. PubMed ID: 20579215
[TBL] [Abstract][Full Text] [Related]
39. Molecular aspects of bile formation and cholestasis.
Arrese M; Trauner M
Trends Mol Med; 2003 Dec; 9(12):558-64. PubMed ID: 14659471
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic analysis of cholestatic liver damage in mice.
Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
